Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Acute Disease

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, R; Fujisawa, H; Graham, DI; Kuroda, Y; Strebel, S1
Bullock, R; Chen, MH; Graham, DI; Inglis, FM; McCulloch, J; Miller, JD1

Other Studies

2 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Acute Disease

ArticleYear
Effect of neuroprotective N-methyl-D-aspartate antagonists on increased intracranial pressure: studies in the rat acute subdural hematoma model.
    Neurosurgery, 1994, Volume: 35, Issue:1

    Topics: Acute Disease; Animals; Disease Models, Animal; Dizocilpine Maleate; Hematoma, Subdural; Hemodynamics; Intracranial Pressure; Male; Mannitol; N-Methylaspartate; Pipecolic Acids; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1994
Ischaemic brain damage associated with tissue hypermetabolism in acute subdural haematoma: reduction by a glutamate antagonist.
    Acta neurochirurgica. Supplementum, 1990, Volume: 51

    Topics: Acute Disease; Animals; Autoradiography; Brain; Brain Damage, Chronic; Brain Ischemia; Cerebrovascular Circulation; Excitatory Amino Acid Antagonists; Glutamic Acid; Hematoma, Subdural; Male; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate

1990